LBRX
LB Pharmaceuticals Inc Common Stock
NASDAQ · Healthcare · Biotechnology · US
$49.34
+3.83%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.84x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.06x
- Net debt / EBITDA
- 3.17x
Liquidity & coverage
- Current ratio
- 15.08x
- Quick ratio
- 15.08x
- Cash ratio
- 13.91x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $331.7M
Cash & dividend
- FCF / debt
- -15.88x
- Cash flow / debt
- -15.79x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026